1776 Massachusetts Ave. NW
Suite 300
Washington, DC 20036
Phone (202) 835-3100
Fax: (202) 835-3150
About us
MCHIP is the USAID Bureau for Global Health's flagship maternal, neonatal and child health (MNCH) program which focuses on reducing maternal, neonatal and child mortality and accelerating progress toward achieving Millennium Development Goals (MDGs) 4 and 5. Awarded to Jhpiego and partners in September 2008, MCHIP works with USAID missions, governments, nongovernmental organizations, local communities and partner agencies in developing countries to implement programs at scale for sustainable improvements in MNCH.
MCHIP and Newborn Health
By focusing on the three main causes of death and supporting the introduction and scale-up of evidence-based prevention and treatment interventions, MCHIP aims to contribute to the global reduction of neonatal mortality. In the process, the Program will be contributing to the reduction in Millennium Development Goal 4, as well as to USAID’s goal of reducing under-five mortality by 25% by 2013 in 30 priority countries, and to their newborn health pathway goals.
The MCHIP strategy for newborn health will:
- Follow the Paris Principles and work with partners including UNICEF, WHO and Saving Newborn Lives to provide catalytic inputs to support the introduction and expansion of evidence-based newborn care interventions;
- Scale up evidence-based approaches to improve newborn health by focusing on 30 priority MCH countries;
- Support integration of ENC packages into MCH systems;
- Assure that evidence-based ENC programs are documented and promoted at scale;
- Provide technical leadership in newborn health globally; and
- Strengthen and support strategic alliances that support implementation of newborn health programs at scale.
Every skilled birth attendant should be able to perform interventions that prevent asphyxia and to resuscitate a non-breathing baby; however, the level of professional expertise among birth attendants in performing these interventions varies widely.
Over 80% of premature babies are born between 32 and 37 weeks of gestation. Most newborn deaths among this group are caused by lack of simple, essential care such as warmth and feeding support.
Severe bacterial infections are a major cause of morbidity and mortality among newborns and young infants in the developing world.
Babies born before 37 weeks gestation are considered preterm babies. Preterm birth (PTB) is the biggest killer of babies worldwide, causing more than 1 million deaths per year.
An estimated 1 in 6 neonatal deaths could be averted with chlorhexidine cord care.
Producing a topical medicine for cord care in low- and middle-income countries - local/regional production as the optimal way to increase the availability of quality, affordable medicine to reduce neonatal mortality.
French language version of Production Strategy.
Umbilical cord cleansing with 7.1% chlorhexidine digluconate saves newborn lives.
Summary:

